3. What Matters About Biomarkers & Blood Tests • Thorvardur Halfdanarson, MD • @NCFCancer11просмотровгод назад
2. What is Neuroendocrine Cancer？ • Bhavana Konda, MD, MPH • Neuroendocrine Cancer Foundation19просмотровгод назад
NCAN Charlotte Patient Conference 2025 - Surgery in Primary & Secondary Neuroendocrine Tumors104просмотрагод назад
NCAN Charlotte Patient Conference 2025 - PRRT Evolution & Future Directions in Clinical Trials31просмотргод назад
NCAN Charlotte Patient Conference 2025 - Hormonal Basics of NETs & Medical Oncology Treatments8просмотровгод назад
NCAN Charlotte Patient Conference 2025 - Interventional Therapies for NET Liver Metastases17просмотровгод назад
07. Systemic Therapy for NETs： Treatment Options for Metastatic Tumors • Heloisa Soares, MD, PhD35просмотровгод назад
Evolving Management of Carcinoid Heart Disease - Prashanth Venkatesh, MD, FACC - April 29, 202515просмотровгод назад
SVV-001 + Ipi-Nivo in Patients With Poorly Differentiated NEC or Well-Differentiated High-Grade NET10просмотровгод назад
Q&A with Experts • Andrew Hendifar, MD, Run Yu, MD, & Jaydira Del Rivero, MD •2024 NET Cancer Day11просмотровгод назад
The Endocrine in Neuroendocrine • Run Yu, MD, Endocrinologist, UCLA •2024 NET Cancer Day Symposium11просмотровгод назад
The Future of NETs： Evolving Treatments & Clinical Trials • Jaydira Del Rivero, MD • 20248просмотровгод назад
The Latest in NET Medical Therapies＂ - Andrew Hendifar, MD, Cedars Sinai • 2024 NET Cancer Day29просмотровгод назад
